Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 6/20 | 0.47 |
| ▸ | ITGB1 | P05556 | 7/20 | 0.46 |
| ▸ | ITGA4 | P13612 | 7/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7429580 | 0.93 | ITGB1 (0.47) | ACHEITGB1ITGA4MEN1GAA | |
| SCHEMBL7425014 | 0.91 | ACHE (0.46) | ACHEITGB1ITGA4MEN1GAA | |
| SCHEMBL7393503 | 0.90 | ACHE (0.49) | ACHEITGB1ITGA4MEN1GAA | |
| SCHEMBL7425392 | 0.89 | ITGB1 (0.44) | ACHEITGB1ITGA4MEN1GAA | |
| SCHEMBL7535877 | 0.88 | ITGA4 (0.43) | ACHEITGB1ITGA4MEN1GAA | |
| SCHEMBL7431414 | 0.88 | ACHE (0.54) | ACHEITGB1ITGA4MEN1GAA | |
| SCHEMBL7428234 | 0.86 | ITGB1 (0.46) | ITGB1ITGA4MEN1GAAKMT2A | |
| SCHEMBL7425433 | 0.86 | ACHE (0.52) | ACHEITGB1ITGA4MEN1GAA | |
| SCHEMBL7430390 | 0.86 | ITGB1 (0.48) | ITGB1ITGA4MEN1GAAKMT2A | |
| SCHEMBL7424839 | 0.86 | ITGA4 (0.43) | ACHEITGB1ITGA4MEN1GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-1999054321-A1 | SUBSTITUTED DIAMINES AND THEIR USE AS CELL ADHESION INHIBITORS | AVENTIS PHARMA LIMITED (GB) | 1999-10-28 | — | — | WO | disclosed |